Atogepant

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 168 publications

Drugs for Migraine Prophylaxis.

Drugs for Migraine Prophylaxis.

Journal: Deutsches Arzteblatt international

Published: January 23, 2026

Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison.

Comparative effectiveness of atogepant and rimegepant for migraine prevention in Japanese patients: an anchored matching-adjusted indirect comparison.

Journal: Expert review of neurotherapeutics

Published: December 18, 2025

Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).

Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study).

Journal: Cephalalgia : an international journal of headache

Published: December 02, 2025

Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis.

Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis.

Journal: Cephalalgia : an international journal of headache

Published: November 28, 2025

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response.

Journal: The journal of headache and pain

Published: October 31, 2025

Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE).

Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE).

Journal: Cephalalgia : an international journal of headache

Published: September 26, 2025

Gepants: targeting the CGRP pathway for migraine relief.

Gepants: targeting the CGRP pathway for migraine relief.

Journal: Frontiers in pharmacology

Published: September 18, 2025

Calcitonin gene-related peptide antagonists in Raynaud's phenomenon: a disproportionality study based on real data and drug-gene network analysis.

Calcitonin gene-related peptide antagonists in Raynaud's phenomenon: a disproportionality study based on real data and drug-gene network analysis.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: September 11, 2025

Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.

Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence.

Journal: Cephalalgia : an international journal of headache

Published: August 28, 2025

Mass Balance and Metabolism of 14C-Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial.

Mass Balance and Metabolism of 14C-Atogepant in Healthy Male Participants: Findings of a Phase 1 Clinical Trial.

Journal: Clinical and translational science

Published: August 25, 2025

Exposure-Response Modeling of Monthly Migraine Days for Efficacy of Atogepant in Patients With Episodic or Chronic Migraine.

Exposure-Response Modeling of Monthly Migraine Days for Efficacy of Atogepant in Patients With Episodic or Chronic Migraine.

Journal: CPT: pharmacometrics & systems pharmacology

Published: August 22, 2025

Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraine.

Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraine.

Journal: Cephalalgia : an international journal of headache

Published: August 20, 2025

Showing 1-12 of 168

Last Updated: 02/24/2026